Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis.
Identifieur interne : 000335 ( Main/Exploration ); précédent : 000334; suivant : 000336Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis.
Auteurs : Dominik Mertz [Canada] ; Tae Hyong Kim ; Jennie Johnstone ; Po-Po Lam ; Michelle Science ; Stefan P. Kuster ; Shaza A. Fadel ; Dat Tran ; Eduardo Fernandez ; Neera Bhatnagar ; Mark LoebSource :
- BMJ (Clinical research ed.) [ 1756-1833 ] ; 2013.
Descripteurs français
- KwdFr :
- Canada (épidémiologie), Complications de la grossesse et maladies infectieuses (), Complications de la grossesse et maladies infectieuses (virologie), Facteurs de risque, Femelle, Grippe humaine (), Grippe humaine (ethnologie), Grippe humaine (immunologie), Grippe humaine (épidémiologie), Grossesse, Hospitalisation (), Humains, Mâle, Pandémies, Répartition par âge, Résultat thérapeutique, Saisons, Soins de réanimation (), Sous-type H1N1 du virus de la grippe A (immunologie), Sous-type H1N1 du virus de la grippe A (pathogénicité), Sélection de patients, Vaccins antigrippaux (administration et posologie).
- MESH :
- administration et posologie : Vaccins antigrippaux.
- ethnologie : Grippe humaine.
- immunologie : Grippe humaine, Sous-type H1N1 du virus de la grippe A.
- pathogénicité : Sous-type H1N1 du virus de la grippe A.
- virologie : Complications de la grossesse et maladies infectieuses.
- épidémiologie : Canada, Grippe humaine.
- Complications de la grossesse et maladies infectieuses, Facteurs de risque, Femelle, Grippe humaine, Grossesse, Hospitalisation, Humains, Mâle, Pandémies, Répartition par âge, Résultat thérapeutique, Saisons, Soins de réanimation, Sélection de patients.
English descriptors
- KwdEn :
- Age Distribution, Canada (epidemiology), Critical Care (statistics & numerical data), Female, Hospitalization (statistics & numerical data), Humans, Influenza A Virus, H1N1 Subtype (immunology), Influenza A Virus, H1N1 Subtype (pathogenicity), Influenza Vaccines (administration & dosage), Influenza, Human (epidemiology), Influenza, Human (ethnology), Influenza, Human (immunology), Influenza, Human (prevention & control), Male, Pandemics, Patient Selection, Pregnancy, Pregnancy Complications, Infectious (prevention & control), Pregnancy Complications, Infectious (virology), Risk Factors, Seasons, Treatment Outcome.
- MESH :
- chemical , administration & dosage : Influenza Vaccines.
- epidemiology : Canada, Influenza, Human.
- ethnology : Influenza, Human.
- immunology : Influenza A Virus, H1N1 Subtype, Influenza, Human.
- pathogenicity : Influenza A Virus, H1N1 Subtype.
- prevention & control : Influenza, Human, Pregnancy Complications, Infectious.
- statistics & numerical data : Critical Care, Hospitalization.
- virology : Pregnancy Complications, Infectious.
- Age Distribution, Female, Humans, Male, Pandemics, Patient Selection, Pregnancy, Risk Factors, Seasons, Treatment Outcome.
Abstract
OBJECTIVE
To evaluate risk factors for severe outcomes in patients with seasonal and pandemic influenza.
DESIGN
Systematic review.
STUDY SELECTION
Observational studies reporting on risk factor-outcome combinations of interest in participants with influenza. Outcomes included death, ventilator support, admission to hospital, admission to an intensive care unit, pneumonia, and composite outcomes.
DATA SOURCES
Medline, Embase, CINAHL, Global Health, and the Cochrane Central Register of Controlled Trials to March 2011.
RISK OF BIAS ASSESSMENT
Newcastle-Ottawa scale to assess the risk of bias. GRADE framework to evaluate the quality of evidence.
RESULTS
63 537 articles were identified of which 234 with a total of 610 782 participants met the inclusion criteria. The evidence supporting risk factors for severe outcomes of influenza ranged from being limited to absent. This was particularly relevant for the relative lack of data for non-2009 H1N1 pandemics and for seasonal influenza studies. Limitations in the published literature included lack of power and lack of adjustment for confounders was widespread: adjusted risk estimates were provided for only 5% of risk factor-outcome comparisons in 39 of 260 (15%) studies. The level of evidence was low for "any risk factor" (odds ratio for mortality 2.77, 95% confidence interval 1.90 to 4.05 for pandemic influenza and 2.04, 1.74 to 2.39 for seasonal influenza), obesity (2.74, 1.56 to 4.80 and 30.1, 1.74 to 2.39), cardiovascular diseases (2.92, 1.76 to 4.86 and 1.97, 1.06 to 3.67), and neuromuscular disease (2.68, 1.91 to 3.75 and 3.21, 1.84 to 5.58). The level of evidence was very low for all other risk factors. Some well accepted risk factors such as pregnancy and belonging to an ethnic minority group could not be identified as risk factors. In contrast, women who were less than four weeks post partum had a significantly increased risk of death from pandemic influenza (4.43, 1.24 to 15.81).
CONCLUSION
The level of evidence to support risk factors for influenza related complications is low and some well accepted risk factors, including pregnancy and ethnicity, could not be confirmed as risks. Rigorous and adequately powered studies are needed.
DOI: 10.1136/bmj.f5061
PubMed: 23974637
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis.</title><author><name sortKey="Mertz, Dominik" sort="Mertz, Dominik" uniqKey="Mertz D" first="Dominik" last="Mertz">Dominik Mertz</name><affiliation wicri:level="4"><nlm:affiliation>Department of Medicine, McMaster University, Hamilton, ON, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Department of Medicine, McMaster University, Hamilton, ON</wicri:regionArea><orgName type="university">Université McMaster</orgName><placeName><settlement type="city">Hamilton (Ontario)</settlement><region type="state">Ontario</region></placeName></affiliation></author><author><name sortKey="Kim, Tae Hyong" sort="Kim, Tae Hyong" uniqKey="Kim T" first="Tae Hyong" last="Kim">Tae Hyong Kim</name></author><author><name sortKey="Johnstone, Jennie" sort="Johnstone, Jennie" uniqKey="Johnstone J" first="Jennie" last="Johnstone">Jennie Johnstone</name></author><author><name sortKey="Lam, Po Po" sort="Lam, Po Po" uniqKey="Lam P" first="Po-Po" last="Lam">Po-Po Lam</name></author><author><name sortKey="Science, Michelle" sort="Science, Michelle" uniqKey="Science M" first="Michelle" last="Science">Michelle Science</name></author><author><name sortKey="Kuster, Stefan P" sort="Kuster, Stefan P" uniqKey="Kuster S" first="Stefan P" last="Kuster">Stefan P. Kuster</name></author><author><name sortKey="Fadel, Shaza A" sort="Fadel, Shaza A" uniqKey="Fadel S" first="Shaza A" last="Fadel">Shaza A. Fadel</name></author><author><name sortKey="Tran, Dat" sort="Tran, Dat" uniqKey="Tran D" first="Dat" last="Tran">Dat Tran</name></author><author><name sortKey="Fernandez, Eduardo" sort="Fernandez, Eduardo" uniqKey="Fernandez E" first="Eduardo" last="Fernandez">Eduardo Fernandez</name></author><author><name sortKey="Bhatnagar, Neera" sort="Bhatnagar, Neera" uniqKey="Bhatnagar N" first="Neera" last="Bhatnagar">Neera Bhatnagar</name></author><author><name sortKey="Loeb, Mark" sort="Loeb, Mark" uniqKey="Loeb M" first="Mark" last="Loeb">Mark Loeb</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2013">2013</date><idno type="RBID">pubmed:23974637</idno><idno type="pmid">23974637</idno><idno type="doi">10.1136/bmj.f5061</idno><idno type="wicri:Area/Main/Corpus">000332</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000332</idno><idno type="wicri:Area/Main/Curation">000332</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000332</idno><idno type="wicri:Area/Main/Exploration">000332</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis.</title><author><name sortKey="Mertz, Dominik" sort="Mertz, Dominik" uniqKey="Mertz D" first="Dominik" last="Mertz">Dominik Mertz</name><affiliation wicri:level="4"><nlm:affiliation>Department of Medicine, McMaster University, Hamilton, ON, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Department of Medicine, McMaster University, Hamilton, ON</wicri:regionArea><orgName type="university">Université McMaster</orgName><placeName><settlement type="city">Hamilton (Ontario)</settlement><region type="state">Ontario</region></placeName></affiliation></author><author><name sortKey="Kim, Tae Hyong" sort="Kim, Tae Hyong" uniqKey="Kim T" first="Tae Hyong" last="Kim">Tae Hyong Kim</name></author><author><name sortKey="Johnstone, Jennie" sort="Johnstone, Jennie" uniqKey="Johnstone J" first="Jennie" last="Johnstone">Jennie Johnstone</name></author><author><name sortKey="Lam, Po Po" sort="Lam, Po Po" uniqKey="Lam P" first="Po-Po" last="Lam">Po-Po Lam</name></author><author><name sortKey="Science, Michelle" sort="Science, Michelle" uniqKey="Science M" first="Michelle" last="Science">Michelle Science</name></author><author><name sortKey="Kuster, Stefan P" sort="Kuster, Stefan P" uniqKey="Kuster S" first="Stefan P" last="Kuster">Stefan P. Kuster</name></author><author><name sortKey="Fadel, Shaza A" sort="Fadel, Shaza A" uniqKey="Fadel S" first="Shaza A" last="Fadel">Shaza A. Fadel</name></author><author><name sortKey="Tran, Dat" sort="Tran, Dat" uniqKey="Tran D" first="Dat" last="Tran">Dat Tran</name></author><author><name sortKey="Fernandez, Eduardo" sort="Fernandez, Eduardo" uniqKey="Fernandez E" first="Eduardo" last="Fernandez">Eduardo Fernandez</name></author><author><name sortKey="Bhatnagar, Neera" sort="Bhatnagar, Neera" uniqKey="Bhatnagar N" first="Neera" last="Bhatnagar">Neera Bhatnagar</name></author><author><name sortKey="Loeb, Mark" sort="Loeb, Mark" uniqKey="Loeb M" first="Mark" last="Loeb">Mark Loeb</name></author></analytic><series><title level="j">BMJ (Clinical research ed.)</title><idno type="eISSN">1756-1833</idno><imprint><date when="2013" type="published">2013</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Age Distribution</term><term>Canada (epidemiology)</term><term>Critical Care (statistics & numerical data)</term><term>Female</term><term>Hospitalization (statistics & numerical data)</term><term>Humans</term><term>Influenza A Virus, H1N1 Subtype (immunology)</term><term>Influenza A Virus, H1N1 Subtype (pathogenicity)</term><term>Influenza Vaccines (administration & dosage)</term><term>Influenza, Human (epidemiology)</term><term>Influenza, Human (ethnology)</term><term>Influenza, Human (immunology)</term><term>Influenza, Human (prevention & control)</term><term>Male</term><term>Pandemics</term><term>Patient Selection</term><term>Pregnancy</term><term>Pregnancy Complications, Infectious (prevention & control)</term><term>Pregnancy Complications, Infectious (virology)</term><term>Risk Factors</term><term>Seasons</term><term>Treatment Outcome</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Canada (épidémiologie)</term><term>Complications de la grossesse et maladies infectieuses ()</term><term>Complications de la grossesse et maladies infectieuses (virologie)</term><term>Facteurs de risque</term><term>Femelle</term><term>Grippe humaine ()</term><term>Grippe humaine (ethnologie)</term><term>Grippe humaine (immunologie)</term><term>Grippe humaine (épidémiologie)</term><term>Grossesse</term><term>Hospitalisation ()</term><term>Humains</term><term>Mâle</term><term>Pandémies</term><term>Répartition par âge</term><term>Résultat thérapeutique</term><term>Saisons</term><term>Soins de réanimation ()</term><term>Sous-type H1N1 du virus de la grippe A (immunologie)</term><term>Sous-type H1N1 du virus de la grippe A (pathogénicité)</term><term>Sélection de patients</term><term>Vaccins antigrippaux (administration et posologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Influenza Vaccines</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Vaccins antigrippaux</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Canada</term><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="ethnologie" xml:lang="fr"><term>Grippe humaine</term></keywords><keywords scheme="MESH" qualifier="ethnology" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Grippe humaine</term><term>Sous-type H1N1 du virus de la grippe A</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Influenza A Virus, H1N1 Subtype</term><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="pathogenicity" xml:lang="en"><term>Influenza A Virus, H1N1 Subtype</term></keywords><keywords scheme="MESH" qualifier="pathogénicité" xml:lang="fr"><term>Sous-type H1N1 du virus de la grippe A</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Influenza, Human</term><term>Pregnancy Complications, Infectious</term></keywords><keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Critical Care</term><term>Hospitalization</term></keywords><keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Complications de la grossesse et maladies infectieuses</term></keywords><keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Pregnancy Complications, Infectious</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Canada</term><term>Grippe humaine</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Age Distribution</term><term>Female</term><term>Humans</term><term>Male</term><term>Pandemics</term><term>Patient Selection</term><term>Pregnancy</term><term>Risk Factors</term><term>Seasons</term><term>Treatment Outcome</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Complications de la grossesse et maladies infectieuses</term><term>Facteurs de risque</term><term>Femelle</term><term>Grippe humaine</term><term>Grossesse</term><term>Hospitalisation</term><term>Humains</term><term>Mâle</term><term>Pandémies</term><term>Répartition par âge</term><term>Résultat thérapeutique</term><term>Saisons</term><term>Soins de réanimation</term><term>Sélection de patients</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p><b>OBJECTIVE</b></p><p>To evaluate risk factors for severe outcomes in patients with seasonal and pandemic influenza.</p></div><div type="abstract" xml:lang="en"><p><b>DESIGN</b></p><p>Systematic review.</p></div><div type="abstract" xml:lang="en"><p><b>STUDY SELECTION</b></p><p>Observational studies reporting on risk factor-outcome combinations of interest in participants with influenza. Outcomes included death, ventilator support, admission to hospital, admission to an intensive care unit, pneumonia, and composite outcomes.</p></div><div type="abstract" xml:lang="en"><p><b>DATA SOURCES</b></p><p>Medline, Embase, CINAHL, Global Health, and the Cochrane Central Register of Controlled Trials to March 2011.</p></div><div type="abstract" xml:lang="en"><p><b>RISK OF BIAS ASSESSMENT</b></p><p>Newcastle-Ottawa scale to assess the risk of bias. GRADE framework to evaluate the quality of evidence.</p></div><div type="abstract" xml:lang="en"><p><b>RESULTS</b></p><p>63 537 articles were identified of which 234 with a total of 610 782 participants met the inclusion criteria. The evidence supporting risk factors for severe outcomes of influenza ranged from being limited to absent. This was particularly relevant for the relative lack of data for non-2009 H1N1 pandemics and for seasonal influenza studies. Limitations in the published literature included lack of power and lack of adjustment for confounders was widespread: adjusted risk estimates were provided for only 5% of risk factor-outcome comparisons in 39 of 260 (15%) studies. The level of evidence was low for "any risk factor" (odds ratio for mortality 2.77, 95% confidence interval 1.90 to 4.05 for pandemic influenza and 2.04, 1.74 to 2.39 for seasonal influenza), obesity (2.74, 1.56 to 4.80 and 30.1, 1.74 to 2.39), cardiovascular diseases (2.92, 1.76 to 4.86 and 1.97, 1.06 to 3.67), and neuromuscular disease (2.68, 1.91 to 3.75 and 3.21, 1.84 to 5.58). The level of evidence was very low for all other risk factors. Some well accepted risk factors such as pregnancy and belonging to an ethnic minority group could not be identified as risk factors. In contrast, women who were less than four weeks post partum had a significantly increased risk of death from pandemic influenza (4.43, 1.24 to 15.81).</p></div><div type="abstract" xml:lang="en"><p><b>CONCLUSION</b></p><p>The level of evidence to support risk factors for influenza related complications is low and some well accepted risk factors, including pregnancy and ethnicity, could not be confirmed as risks. Rigorous and adequately powered studies are needed.</p></div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">23974637</PMID><DateCompleted><Year>2013</Year><Month>11</Month><Day>13</Day></DateCompleted><DateRevised><Year>2019</Year><Month>01</Month><Day>11</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1756-1833</ISSN><JournalIssue CitedMedium="Internet"><Volume>347</Volume><PubDate><Year>2013</Year><Month>Aug</Month><Day>23</Day></PubDate></JournalIssue><Title>BMJ (Clinical research ed.)</Title><ISOAbbreviation>BMJ</ISOAbbreviation></Journal><ArticleTitle>Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis.</ArticleTitle><Pagination><MedlinePgn>f5061</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1136/bmj.f5061</ELocationID><ELocationID EIdType="pii" ValidYN="Y">bmj.f5061</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To evaluate risk factors for severe outcomes in patients with seasonal and pandemic influenza.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Systematic review.</AbstractText><AbstractText Label="STUDY SELECTION" NlmCategory="METHODS">Observational studies reporting on risk factor-outcome combinations of interest in participants with influenza. Outcomes included death, ventilator support, admission to hospital, admission to an intensive care unit, pneumonia, and composite outcomes.</AbstractText><AbstractText Label="DATA SOURCES" NlmCategory="METHODS">Medline, Embase, CINAHL, Global Health, and the Cochrane Central Register of Controlled Trials to March 2011.</AbstractText><AbstractText Label="RISK OF BIAS ASSESSMENT" NlmCategory="UNASSIGNED">Newcastle-Ottawa scale to assess the risk of bias. GRADE framework to evaluate the quality of evidence.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">63 537 articles were identified of which 234 with a total of 610 782 participants met the inclusion criteria. The evidence supporting risk factors for severe outcomes of influenza ranged from being limited to absent. This was particularly relevant for the relative lack of data for non-2009 H1N1 pandemics and for seasonal influenza studies. Limitations in the published literature included lack of power and lack of adjustment for confounders was widespread: adjusted risk estimates were provided for only 5% of risk factor-outcome comparisons in 39 of 260 (15%) studies. The level of evidence was low for "any risk factor" (odds ratio for mortality 2.77, 95% confidence interval 1.90 to 4.05 for pandemic influenza and 2.04, 1.74 to 2.39 for seasonal influenza), obesity (2.74, 1.56 to 4.80 and 30.1, 1.74 to 2.39), cardiovascular diseases (2.92, 1.76 to 4.86 and 1.97, 1.06 to 3.67), and neuromuscular disease (2.68, 1.91 to 3.75 and 3.21, 1.84 to 5.58). The level of evidence was very low for all other risk factors. Some well accepted risk factors such as pregnancy and belonging to an ethnic minority group could not be identified as risk factors. In contrast, women who were less than four weeks post partum had a significantly increased risk of death from pandemic influenza (4.43, 1.24 to 15.81).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The level of evidence to support risk factors for influenza related complications is low and some well accepted risk factors, including pregnancy and ethnicity, could not be confirmed as risks. Rigorous and adequately powered studies are needed.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mertz</LastName><ForeName>Dominik</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Medicine, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Tae Hyong</ForeName><Initials>TH</Initials></Author><Author ValidYN="Y"><LastName>Johnstone</LastName><ForeName>Jennie</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Lam</LastName><ForeName>Po-Po</ForeName><Initials>PP</Initials></Author><Author ValidYN="Y"><LastName>Science</LastName><ForeName>Michelle</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Kuster</LastName><ForeName>Stefan P</ForeName><Initials>SP</Initials></Author><Author ValidYN="Y"><LastName>Fadel</LastName><ForeName>Shaza A</ForeName><Initials>SA</Initials></Author><Author ValidYN="Y"><LastName>Tran</LastName><ForeName>Dat</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Fernandez</LastName><ForeName>Eduardo</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Bhatnagar</LastName><ForeName>Neera</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Loeb</LastName><ForeName>Mark</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D059040">Video-Audio Media</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>08</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ</MedlineTA><NlmUniqueID>8900488</NlmUniqueID><ISSNLinking>0959-8138</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>AIM</CitationSubset><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Evid Based Med. 2014 Jun;19(3):110</RefSource><PMID Version="1">24357401</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D017677" MajorTopicYN="N">Age Distribution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002170" MajorTopicYN="N">Canada</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003422" MajorTopicYN="N">Critical Care</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053118" MajorTopicYN="N">Influenza A Virus, H1N1 Subtype</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000208" MajorTopicYN="N">ethnology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018579" MajorTopicYN="N">Patient Selection</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011251" MajorTopicYN="N">Pregnancy Complications, Infectious</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012621" MajorTopicYN="N">Seasons</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>8</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>8</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>11</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23974637</ArticleId><ArticleId IdType="pmc">PMC3805492</ArticleId><ArticleId IdType="doi">10.1136/bmj.f5061</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>BMJ. 2003 Sep 6;327(7414):557-60</Citation><ArticleIdList><ArticleId IdType="pubmed">12958120</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2004 Jun 19;328(7454):1490</Citation><ArticleIdList><ArticleId IdType="pubmed">15205295</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2005 Apr 20;293(15):1861-7</Citation><ArticleIdList><ArticleId IdType="pubmed">15840860</ArticleId></ArticleIdList></Reference><Reference><Citation>Stat Med. 2006 Oct 30;25(20):3443-57</Citation><ArticleIdList><ArticleId IdType="pubmed">16345038</ArticleId></ArticleIdList></Reference><Reference><Citation>Contemp Clin Trials. 2008 Sep;29(5):762-6</Citation><ArticleIdList><ArticleId IdType="pubmed">18639651</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Emerg Care. 2009 Jun;25(6):369-75</Citation><ArticleIdList><ArticleId IdType="pubmed">19458562</ArticleId></ArticleIdList></Reference><Reference><Citation>Wkly Epidemiol Rec. 2009 Jul 24;84(30):301-4</Citation><ArticleIdList><ArticleId IdType="pubmed">19630186</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2010 Jan 7;362(1):27-35</Citation><ArticleIdList><ArticleId IdType="pubmed">20032319</ArticleId></ArticleIdList></Reference><Reference><Citation>CMAJ. 2010 Mar 9;182(4):349-55</Citation><ArticleIdList><ArticleId IdType="pubmed">20159893</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Epidemiol. 2010 Aug;63(8):926-31</Citation><ArticleIdList><ArticleId IdType="pubmed">20303710</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2010 Apr 21;303(15):1517-25</Citation><ArticleIdList><ArticleId IdType="pubmed">20407061</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Infect Dis J. 2010 Jul;29(7):585-90</Citation><ArticleIdList><ArticleId IdType="pubmed">20589966</ArticleId></ArticleIdList></Reference><Reference><Citation>MMWR Recomm Rep. 2010 Aug 6;59(RR-8):1-62</Citation><ArticleIdList><ArticleId IdType="pubmed">20689501</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Infect Dis. 2010 Aug 27;10:256</Citation><ArticleIdList><ArticleId IdType="pubmed">20799934</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2010 Oct 05;5(10):null</Citation><ArticleIdList><ArticleId IdType="pubmed">20957195</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Pediatr Adolesc Med. 2010 Nov;164(11):1015-22</Citation><ArticleIdList><ArticleId IdType="pubmed">21041594</ArticleId></ArticleIdList></Reference><Reference><Citation>CMAJ. 2010 Dec 14;182(18):1981-7</Citation><ArticleIdList><ArticleId IdType="pubmed">21059773</ArticleId></ArticleIdList></Reference><Reference><Citation>Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2010 Dec;53(12):1223-30</Citation><ArticleIdList><ArticleId IdType="pubmed">21161471</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2011 Feb 1;52(3):301-12</Citation><ArticleIdList><ArticleId IdType="pubmed">21208911</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2011 Feb 10;342:d549</Citation><ArticleIdList><ArticleId IdType="pubmed">21310794</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Med. 2011 Jul;8(7):e1001053</Citation><ArticleIdList><ArticleId IdType="pubmed">21750667</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Epidemiol. 2011 Dec;64(12):1283-93</Citation><ArticleIdList><ArticleId IdType="pubmed">21839614</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2011;6(10):e25491</Citation><ArticleIdList><ArticleId IdType="pubmed">22028777</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Intern Med. 2012 Apr 3;156(7):512-24</Citation><ArticleIdList><ArticleId IdType="pubmed">22371849</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Infect Dis. 2012 Sep;12(9):687-95</Citation><ArticleIdList><ArticleId IdType="pubmed">22738893</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Med. 2013;10(2):e1001380</Citation><ArticleIdList><ArticleId IdType="pubmed">23393429</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2013;8(4):e60348</Citation><ArticleIdList><ArticleId IdType="pubmed">23565231</ArticleId></ArticleIdList></Reference><Reference><Citation>JBI Libr Syst Rev. 2012;10(56 Suppl):1-11</Citation><ArticleIdList><ArticleId IdType="pubmed">27820287</ArticleId></ArticleIdList></Reference><Reference><Citation>Control Clin Trials. 1986 Sep;7(3):177-88</Citation><ArticleIdList><ArticleId IdType="pubmed">3802833</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 1997 Sep 13;315(7109):629-34</Citation><ArticleIdList><ArticleId IdType="pubmed">9310563</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 1998 Nov 18;280(19):1690-1</Citation><ArticleIdList><ArticleId IdType="pubmed">9832001</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Epidemiol. 1998 Dec 1;148(11):1094-102</Citation><ArticleIdList><ArticleId IdType="pubmed">9850132</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>Canada</li></country><region><li>Ontario</li></region><settlement><li>Hamilton (Ontario)</li></settlement><orgName><li>Université McMaster</li></orgName></list><tree><noCountry><name sortKey="Bhatnagar, Neera" sort="Bhatnagar, Neera" uniqKey="Bhatnagar N" first="Neera" last="Bhatnagar">Neera Bhatnagar</name><name sortKey="Fadel, Shaza A" sort="Fadel, Shaza A" uniqKey="Fadel S" first="Shaza A" last="Fadel">Shaza A. Fadel</name><name sortKey="Fernandez, Eduardo" sort="Fernandez, Eduardo" uniqKey="Fernandez E" first="Eduardo" last="Fernandez">Eduardo Fernandez</name><name sortKey="Johnstone, Jennie" sort="Johnstone, Jennie" uniqKey="Johnstone J" first="Jennie" last="Johnstone">Jennie Johnstone</name><name sortKey="Kim, Tae Hyong" sort="Kim, Tae Hyong" uniqKey="Kim T" first="Tae Hyong" last="Kim">Tae Hyong Kim</name><name sortKey="Kuster, Stefan P" sort="Kuster, Stefan P" uniqKey="Kuster S" first="Stefan P" last="Kuster">Stefan P. Kuster</name><name sortKey="Lam, Po Po" sort="Lam, Po Po" uniqKey="Lam P" first="Po-Po" last="Lam">Po-Po Lam</name><name sortKey="Loeb, Mark" sort="Loeb, Mark" uniqKey="Loeb M" first="Mark" last="Loeb">Mark Loeb</name><name sortKey="Science, Michelle" sort="Science, Michelle" uniqKey="Science M" first="Michelle" last="Science">Michelle Science</name><name sortKey="Tran, Dat" sort="Tran, Dat" uniqKey="Tran D" first="Dat" last="Tran">Dat Tran</name></noCountry><country name="Canada"><region name="Ontario"><name sortKey="Mertz, Dominik" sort="Mertz, Dominik" uniqKey="Mertz D" first="Dominik" last="Mertz">Dominik Mertz</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/GrippeCanadaV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000335 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000335 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= GrippeCanadaV3
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:23974637
|texte= Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:23974637" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a GrippeCanadaV3
| This area was generated with Dilib version V0.6.35. |  |